Cardiovascular Disease· Topic 2.3 Ischemic heart disease· 2.3.4

Unstable angina

Unstable angina is acute myocardial ischemia from a non-occlusive coronary thrombus causing rest, new, or crescendo angina without a troponin rise, placing it on the acute coronary syndrome spectrum just short of NSTEMI. Diagnosis is clinical with ischemic ECG changes and negative serial troponins, and management mirrors NSTE-ACS with antithrombotic therapy and risk-guided angiography.

5 min read9 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: unstable angina is acute myocardial ischemia caused by a non-occlusive coronary thrombus, presenting as rest, new-onset, or crescendo angina without myocardial necrosis.

  • Epidemiology

    A common ACS presentation, though high-sensitivity troponin assays now reclassify many former cases as NSTEMI.

  • Risk factors

    Atherosclerotic risk factors: smoking, diabetes, hypertension, dyslipidemia, and family history.

  • Pathophysiology

    Non-occlusive thrombus: plaque rupture or erosion produces a partially occlusive thrombus that limits flow without causing necrosis.

  • Clinical features

    Rest angina: ischemic pain occurring at rest, usually lasting more than 20 minutes.

  • Differential diagnosis

    NSTEMI: identical presentation but with a troponin rise (NSTEMI).

  • Diagnosis

    Establish clinically as ischemia without infarction: unstable angina is diagnosed by rest, new, or crescendo anginal symptoms with or without ischemic ECG changes (ST depression or T-wave inversion)…

  • Management

    First, give antiplatelet and anticoagulant therapy: Aspirin 325 mg chewed once, then 81 mg PO daily indefinitely.

  • Complications

    Progression to myocardial infarction: the principal risk.

  • Prognosis

    Elevated short-term risk of infarction and death, quantified by risk scores.

  • Prevention

    Secondary prevention: aspirin, high-intensity statin to an LDL goal below 70 mg/dL, dual antiplatelet therapy for the recommended duration.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.